drugset / Trial / NCT01179490
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
The study objectives of this study are to determine the effects, safety, and pharmacokinetics of bendamustine for multiple myeloma to a regimen of bendamustine and prednisolone.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bendamustine | Small molecule | 150 mg/m2 | Intravenous |
| Background | Prednisolone | Other / unclassified | 60 mg/m2 | Oral |